RxDoctor Payments Data

Barry Siegel, MD

Nuclear Medicine · Saint Louis, MONPI 1730107202

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $44,939 of the $53,586 with a category attached, or 83.9%. 6 manufacturers reported payments, led by Progenics Pharmaceuticals, Inc. at 58.7% of the total. Reporting peaked in 2020 at $15,492 and has fallen 82.0% since, to $2,782 in 2025. Among nuclear medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$53,586in general payments, 2019–2025

Across 88 payments — averaging $608.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Progenics Pharmaceuticals, Inc.$31K
  • Avid Radiopharmaceuticals, Inc.$9K
  • Curium US LLC$8K
  • GE HealthCare$4K
  • Siemens Medical Solutions USA, Inc.$2K
  • Eli Lilly$130
$1,161,157in research payments, 2019–2025

Across 34 payments — averaging $34,152 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Progenics Pharmaceuticals, Inc.$694K
  • Blue Earth Diagnostics$467K

What the payments were for

  • Consulting fees$44,93984%
  • Speaking & faculty fees$3,0976%
  • Travel & lodging$2,9496%
  • Food & beverage$2,6015%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$53,586 in reported general payments places this provider in the 95th percentile of 21 nuclear medicine providers in Missouri.

See all nuclear medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$28,413
Medicare patients
416
Services billed
435

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →